Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.
about
Cancer cachexia--pathophysiology and managementRole of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factorEnergy balance and metabolism after cancer treatmentThe anti-cachectic effect of fatty acids.Clinical undernutrition states and their influence on taste.Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.Pathophysiology of cancer cachexia.A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.Cancer cachexia: mechanisms and clinical implications.Cancer cachexia, mechanism and treatmentNutritional support in cancer patients.Resting energy expenditure in patients undergoing pylorus preserving pancreatoduodenectomies for bile duct cancer or pancreatic tumors.The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapyNutritional status of patients with locally advanced pancreatic cancer: a pilot study.Resting energy expenditure and nutritional status in patients undergoing transthoracic esophagectomy for esophageal cancerMetabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls.Research methodology: cancer cachexia syndrome.Comparison of Resting Energy Expenditure Between Cancer Subjects and Healthy Controls: A Meta-Analysis.Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinomaIbuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patientsThe relationship between weight loss and interleukin 6 in non-small-cell lung cancerAdipose tissue lipolysis and energy metabolism in early cancer cachexia in mice.The cancer cachexia syndrome: a review of metabolic and clinical manifestations.The origins of cachexia in acute and chronic inflammatory diseases.Changes in nutritional status associated with unresectable pancreatic cancer.The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma.Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer.Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced diseaseSurvival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer.Changes in dietary intake, body weight, nutritional status, and metabolic rate in a pancreatic cancer patientThe influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.Energy metabolism and nutritional status in hospitalized patients with lung cancerDiet and nutrition in cancer survivorship and palliative care.Role of survivor bias in pancreatic cancer case-control studies.
P2860
Q24605567-A3D4031D-655E-43C7-BB97-A2F4153B624DQ24643312-1DAC5856-352E-4CFB-ABFF-C7E056E6DCD8Q27015118-DCF2A4F2-F335-4B1F-8BF3-9F7B8FE90FEDQ33545959-28E28FDE-7350-48DF-A071-05D4E6CF9D7DQ33545976-52A28796-9310-4568-BABD-1F9DBBECE327Q33723662-107DB58C-F7E3-4AAE-B90C-CFABE39E9837Q33874156-0F210763-C3BC-45A8-9D84-4245C2CF4CE7Q34139514-81A94206-6BC6-4ED0-BE65-10BB940E107FQ34502402-0C7A90CC-4B13-41B7-8BA2-A48D7ADD9B1BQ34631019-2A0761AA-47C3-4F65-BB92-D0F0E7A337B7Q34669440-B13EE71A-4DD4-410E-8A07-5DF756963E9DQ34823554-09593E12-DDAD-4FF1-AFF5-3727C21EA31FQ34853013-33E57EB1-3EF3-4A70-96F2-5AD66E5679CFQ35018650-3F4B45BD-25D1-4BF4-B92C-BC1F7774EDF9Q35112838-62C94BB9-F5CE-473D-8621-987E2FBC0967Q35522337-DB473727-C653-437D-A667-9121456445AAQ35563502-F536F852-8527-4A6D-AA07-516F4738E292Q35872798-FB976103-6A1E-44E8-AB84-489257B907E4Q35967639-E1A3A897-68B9-4271-9E6B-2798CD5FA0B4Q36015280-CD3E45B9-D714-4C81-8FB6-4D0D3D8EB2CEQ36026144-E0138BD1-577F-4B71-B731-13BC7433A648Q36081975-5B7906B5-0DF8-408F-AC7F-8D602F7E3957Q36135375-80811B67-4817-4326-8739-1FC03C6E7BB1Q36213681-E0F2990B-EB5C-456D-B89E-8FEE68D0A417Q36278394-76C752C1-EB0A-4AD3-91B8-2EF4647B1D25Q36378758-5DE4DF6C-CD21-4379-A076-FECEE61D8559Q36419986-DF4D112F-1EDE-4819-93D3-30D84A6B9A35Q36431605-846CED46-CE4A-4B5A-853D-C1F47427EA49Q36612480-2E5AF916-A17A-444C-906B-D0018278014FQ36621512-D49D5865-2D27-43B4-95A4-BE2F89AEA75FQ36694660-5C05D4FA-6B3A-4F4F-9F22-634D569449B9Q36876297-A5F5A026-A978-40E3-B2DB-88E8D8AF142BQ36916317-46052B70-111A-41F2-9D4A-0D4C5733E701Q37057667-83D60F5D-FAC1-40CA-92D3-60FDD5DFCFBEQ37080980-A4FF34A2-07F9-4062-968B-FDF04060BCC1Q37152934-ACBFA7C1-DFE2-414F-AAD6-0AE6C535A474Q37154729-15E951EB-E567-47C6-8F25-9BB074DF100BQ37247027-E97824AA-83AB-42E0-9044-381DAAD69D97Q37322307-47A871BB-C7FC-448D-8C0D-879B1617F508Q37357504-71C6BC83-8C50-48A4-A71B-825BABD18913
P2860
Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cytokines, the acute-phase res ...... tients with pancreatic cancer.
@en
Cytokines, the acute-phase res ...... tients with pancreatic cancer.
@nl
type
label
Cytokines, the acute-phase res ...... tients with pancreatic cancer.
@en
Cytokines, the acute-phase res ...... tients with pancreatic cancer.
@nl
prefLabel
Cytokines, the acute-phase res ...... tients with pancreatic cancer.
@en
Cytokines, the acute-phase res ...... tients with pancreatic cancer.
@nl
P2093
P1433
P1476
Cytokines, the acute-phase res ...... tients with pancreatic cancer.
@en
P2093
P304
P356
10.1097/00000658-199404000-00001
P407
P577
1994-04-01T00:00:00Z